Genomic solutions & clinical action
The insights that personalize care
Moving from reactive to predictive, our genomic sequencing solutions utilize the power of genomics to help inform clinical decisions in an easy and approachable way.
Why you should take action
of people have taken a health-risk genetic test¹
spend on adverse drug reactions annually²
emergency department visits each year due to adverse drug events³
cost of medical services for breast cancer in 2020⁴
Our genetic testing solutions
Carrier Screening
This test determines the carrier status for over 500 inherited diseases and rare conditions for prospective or currently pregnant parents
Newborn Screening
Our test screens newborns for early childhood single-gene diseases, for which medical preventive, surveillance, or treatment interventions are possible
Hereditary Heart Disease Screening
Our hereditary cardiovascular disease test provides insight into risk for over 25 cardiovascular diseases or syndromes linked to heart disease
Pharmacogenomics
This broad pharmacogenomics (PGx) solution analyzes an individual's DNA to identify variants that may affect their response to certain drugs
Custom Exome Slice Panel
Choose from a few hundred genes to create a custom panel for your unique clinical utility
Whole Genome Sequencing
This whole genome sequencing (WGS) test provides insights around health, carrier status for certain conditions, lifestyle traits, and ancestry
Who is this solution for?
Health plans
Facilitate better healthcare for each of your members.
Employers
Offer competitive benefits to empower your workforce.
Public sector
Empower your constituents with personalized care.
Health systems
Leverage key health insights to guide your patients' healthcare.
Life sciences
Transform pharmaceutical healthcare delivery.
What sets us apart?
State-of-the-art owned labs
With CLIA Certification and CAP accreditation, the LetsGetChecked labs operate with gold-standard quality practices on a global level. Ownership of our own Laboratory infrastructure fuels the freedom to design panels that are optimized for specific population needs.
Making genomics approachable
Genetic data can be overwhelming, but our roots lie in an unbeatable patient-centric experience that focuses on education and engagement, driving results by empowering patients and providers.
Targeted engagement strategies
Expert-led online education hub
All-in-one secure patient portal
Configurable program design to achieve your goals
Our technology makes it easy to integrate our solution into your existing program infrastructure.
Real-time reporting portal
Powerful data visualizations
API technology
End-to-end care services to drive action
We have designed a solution to help patients and providers understand the next best steps to take post-result.
Counselling services from genetic experts
Regular screening plans for those who need closer monitoring
Clinical decision support
Integrated pharmacy services to put pharmacogenomic insights into action
Dr. Avni Santani
Chief Genomics Officer
Dr. Robert Mordkin, MD
Chief Medical Officer
Dr. Kate Karfilis
Director of Product - Genomics
Michael Rummel
Chief Laboratory Officer
Request a demo
Learn more about our solution suite
myPGx
Genetic variations influence how we react to medications, which can lead to reduced efficacy and adverse side effects. This broad at-home PGx solution identifies potential drug-gene interactions for 100+ drugs across three major disease categories, representing 1 billion prescriptions, annually.
Behavioral health, pain, and cardiovascular drugs
Patient-friendly test and experience
Clinical decision support
A simple patient experience
At-home sample collection
Simple saliva sample kits sent to the home and returned to our lab
Genetics education hub
Empower & inform with our expert-led information hub
Result report delivery
Online through their secure dashboard for easy access
Counselling services
Access to experts to better understand results
Clinical decision support
Guidance for HCPs from genetic experts
Published research
Slice Testing-Considerations from Ordering to Reporting: A Joint Report of the Association for Molecular Pathology, College of American Pathologists, and National Society of Genetic Counselors
Implementation, Evolution, and Laboratory Performance of Methods-Based Proficiency Testing for Next-Generation Sequencing Detection of Germline Sequence Variants
A Framework of Critical Considerations in Clinical Exome Reanalyses by Clinical and Laboratory Standards Institute
Applications of genome sequencing as a single platform for clinical constitutional genetic testing
Known pathogenic gene variants and new candidates detected in Sudden Unexpected Infant Death using Whole Genome Sequencing
Related articles
Request a demo
Get in touch with us so we can design your solution
1. Attitudes towards and sociodemographic determinants of genetic test usage in the USA; data from the Health Information National Trend Survey, 2020 - J Genet Couns
2. Clinical and economic burden of adverse drug reactions - J Pharmacol Pharmacother. 2013
3. CDC - Adverse Drug Events in Adults
4. NIH - Adverse Drug Events in Adults
5. NIH - Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users
6. Cancer.Net - Lynch Syndrome
Dr. Avni Santani
Chief Genomics Officer
Dr. Robert Mordkin, MD
Chief Medical Officer
Dr. Kate Karfilis
Director of Product - Genomics
Michael Rummel
Chief Laboratory Officer